Can we improve survival with less overall morbidity for patients with intermediate-risk cervical cancer without the use of external beam radiotherapy?

The value of the Sedlis criteria[1][1] based on tumor size, depth of stromal invasion, and lymphovascular space invasion as guidance for prescribing post-operative adjuvant external beam radiotherapy in patients with intermediate-risk cervical cancer is a subject of debate.[2][2] The CERVANTES